📋 Tender Overview
Contract awarded for General anti-infective medications for systemic use, vaccines, antineoplastic and immunomodulatory agents lot-0001, title: acyclovir tablets 200 mg, description: framework agreement minimum quantity 400 tablets - maximum quantity 800 tablets lot-0006, title: albendazole tablets 200 mg, description: framework agreement minimum quantity 50 tablets - maximum quantity 100 tablets lot-0014, title: hydrogen peroxide 3% fl 3% 200ml, description: framework agreement minimum quantity 500 tablets - maximum quantity 1000 tablets lot-0024, title: calcium lactate tablets, description: framework agreement minimum quantity 2500 tablets - maximum quantity 5000 tablets lot-0029, title: chlorquinaldol 100 mg dragee, description: framework agreement minimum quantity 300 dragee - maximum quantity 600 dragee lot-0033, title: chloramphenicol + fluocinolone + lidocaine bottle 10 ml ear drops solution, description: framework agreement minimum quantity 100 bottles - maximum quantity 200 bottles lot-0034, title: benzalkonium chloride/chlorhexidine digluconate (dermobacter) bottle 5+2mg/ml (300ml) skin solution, description: framework agreement minimum quantity 100 bottles - maximum quantity 200 bottles lot-0036, title: clotrimazole vaginal tablets 100mg vaginal tablets, description: framework agreement minimum quantity 50 tablets - maximum quantity 100 tablets lot-0042, title: cream with vitamin a e c cream, description: framework agreement minimum quantity 100 creams - maximum quantity 200 creams lot-0044, title: decasept tablets, description: framework agreement minimum quantity 15000 tablets - maximum quantity 30000 tablets lot-0050, title: glycerin borax solution 10%, description: framework agreement minimum quantity 125 bottles - maximum quantity 250 bottles lot-0058, title: magnesium + vitamin b6 tablets, description: framework agreement minimum quantity 20000 tablets - maximum quantity 40000 tablets lot-0061, title: moxifloxacin tablets 400mg, description: framework agreement minimum quantity 75 tablets - maximum quantity 150 tablets lot-0064, title: norfloxacin capsules 400 mg, description: framework agreement minimum quantity 2250 tablets - maximum quantity 4500 tablets lot-0074, title: rivanol solution 1‰ 200ml solution, description: framework agreement minimum quantity 300 solutions - maximum quantity 600 solutions lot-0075, title: methylene blue solution 1% oral solution for external use, description: framework agreement minimum quantity 50 bottles - maximum quantity 100 bottles lot-0077, title: sulfamethoxazole + trimethoprim bottle 25 mg/ 25 mg oral suspension, description: framework agreement minimum quantity 25 bottles - maximum quantity 50 bottles lot-0101, title: aceclofenac tablets 100mg, description: framework agreement minimum quantity 350 tablets - maximum quantity 700 tablets. lot-0102, title: acetylsalicylic acid buffered tablets 500 mg, description: framework agreement minimum quantity 250 tablets - maximum quantity 500 tablets. lot-0103, title: chlorzoxazone tablets 250 mg, description: framework agreement minimum quantity 12500 tablets - maximum quantity 25000 tablets. lot-0110, title: diclofenac tablets 100 mg, description: framework agreement minimum quantity 2000 tablets - maximum quantity 4000 tablets. lot-0117, title: meloxicam tablets 15 mg, description: framework agreement minimum quantity 500 tablets - maximum quantity 1000 tablets. lot-0125, title: nidoflor tube 15 g, description: framework agreement minimum quantity 150 tubes - maximum quantity 300 tubes lot-0131, title: tramadol + paracetamol tablets 37.5/325, description: framework agreement minimum quantity 2000 tablets - maximum quantity 4000 tablets. lot-0132, title: sodium naproxen tablets 550mg, description: framework agreement minimum quantity 500 tablets - maximum quantity 1000 tablets. lot-0133, title: sodium naproxen tablets 275mg, description: framework agreement minimum quantity 400 tablets - maximum quantity 800 tablets. estimated value excluding vat: 315.00 ron.General anti-infective medications for systemic use, vaccines, antineoplastic and immunomodulatory agents
